Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-20 Option Award |
2025-03-21 4:48 pm |
N/A 2035-03-20 |
Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-08-20 Option Award |
2024-08-22 4:09 pm |
N/A 2034-08-20 |
Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-09-19 Option Award |
2023-09-20 5:48 pm |
N/A 2033-09-19 |
Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 5:08 pm |
N/A 2032-06-01 |
Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-05-12 Option Award |
2022-05-16 5:11 pm |
N/A 2032-05-12 |
Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-12-28 Equity Swap |
2021-12-29 4:19 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director |
3,333 | $38.25 | 0 (Direct) |
View |
| 2021-06-03 Exercise |
2021-06-07 9:32 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director |
3,333 | $0 | 21,666 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 9:32 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director |
18,333 | $0 | 21,666 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-16 8:02 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | Doberstein Stephen K Director |
18,333 | $0 | 18,333 (Direct) |
View |